(PharmaNewsWire.Com, November 21, 2017 ) According to the report Breast Biopsy Market, published by Market Data Forecast, the Global market is projected to reach USD 807.4 million by 2022, at a CAGR of 10.8% from 2017 to 2022
Breast Biopsy is the final test required to confirm the presence of cancerous tumor in the case of breast cancer. A tissue or fluid is taken from the area where the tumor is believed to be present. The sample is then examined by conducting several tests to determine whether the tissue is cancerous or not. Almost 80% of the women who undergo biopsy are not diagnosed with breast cancer.
Breast Biopsy Market: Drivers & Restraints Growing awareness regarding the breast cancer through government campaigns and increasing prevalence of breast cancer in adult women are the major factors driving the market growth. Technological advancements, increased risk of hereditary cancer and minimally invasive devices for performing biopsy are expected to propel the market growth.
However, improper guidelines regarding the regulations on devices and high cost of the procedures are hindering the market growth.
Breast Biopsy Market: Segmentation By Product • Biopsy needles • Guidance systems • Biopsy tables • Localization wires • Others
By Type • Needle breast biopsy o Core needle biopsy o Fine needle aspiration biopsy o Vacuum assisted biopsy • Open surgical breast biopsy o Excisional breast biopsy o Incisional breast biopsy
By Guidance • Mammography-Guided Stereotactic Breast Biopsy • Ultrasound-Guided Breast Biopsy • MRI-Guided Breast Biopsy • Other Guidance Techniques
By Geography • North America o United States o Canada • Europe o U.K o Spain o Germany o Italy o France • Asia Pacific o China o India o Japan o Australia o South Korea • Latin America o Brazil o Argentina o Mexico o Rest of Latin America • Middle East & Africa o Middle East o Africa
Breast Biopsy Market: Overview Based on product, Biopsy needles hold the largest market share. It is because they are the most commonly used instruments to perform a biopsy. Based on type of biopsy, needle breast biopsy is the largest market segment. It is correlated with the biopsy needles market. Fine needle aspiration biopsy is the most commonly used type of biopsy. Based on guidance, mammography-guided stereotactic breast biopsy is the most efficient guiding technique available in the market.
North America leads the breast biopsy market. North America has the highest percentage of women diagnosed with breast cancer and hence it increases the demand for breast biopsy devices. Asia Pacific is the fastest growing market segment due to its huge population base. Majority of its adult female population has never been tested for breast cancer and due to the increasing awareness among people, the market growth looks promising.
Breast Biopsy Market: Key Players Major players in the Breast Biopsy market are Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC., Ethicon Endo Surgery (Johnson & Johnson), Intact Medical Corporation, and Galini SRL.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, http://www.marketdataforecast.com/.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
